Figure 1 | British Journal of Cancer

Figure 1

From: Blockade of SDF-1/CXCR4 signalling inhibits pancreatic cancer progression in vitro via inactivation of canonical Wnt pathway

Figure 1

The expression of CXCR4 on pancreatic cancers. (A) immunohistochemistry staining of CXCR4 on normal pancreatic tissues (a) and pancreatic cancer tissues (b–d) × 200: negative expression (a), weak expression (b), moderate expression (c), strong expression (d); (B) Kaplan–Meier curve showed that the median survival time of the CXCR4-positive and CXCR4-negative groups was 5.5 and 13.5 months; (C). Western blot analysis revealed the CXCR4 expression for 5 pancreatic cancer cells (PC-2, PC-3, Miapaca-2, Bxpc-3, Panc-1). GAPDH was used as a loading control.

Back to article page